No Data
Sihuan Biology: Jiangsu Sihuan Biology Co., Ltd. 2024 annual performance forecast
Jiangsu Sihuan Bioengineering (000518.SZ): Qiu Weibin will become the actual controller of the company.
Jiangsu Sihuan Bioengineering (000518.SZ) announced that on January 20, 2025, Bihui Investment received a court notice from the Jiangyin Court...
Jiangsu Sihuan Bioengineering (000518.SZ): Expected loss of 68 million yuan to 0.1 billion yuan in 2024.
On January 21, Gelonghui reported that Jiangsu Sihuan Bioengineering (000518.SZ) expects revenue in 2024 to be between 180 million yuan and -220 million yuan, with a loss of 68 million yuan to 100 million yuan, and a non-recurring loss of 63 million yuan to 95 million yuan. The main reasons for the company's performance loss during this reporting period are: the company increased related costs due to disputes over false representations in securities; affected by competition in the pharmaceutical market, the main business revenue of Peking Sihuan Bioengineering Co., Ltd. declined, resulting in performance losses; and the inventory assets (seedlings) of Jiangsu Chenwei Ecological Park Technology Co., Ltd. were impacted by the market environment.
Jiangsu Sihuan Bioengineering (000518.SZ): Subsidiary Chenwei Ecological Park has been included in the list of dishonest persons subject to enforcement.
On December 13, Gelonghui reported that Jiangsu Sihuan Bioengineering (000518.SZ) announced that its wholly-owned subsidiary, Jiangsu Chenwei Ecological Park Technology Co., Ltd. (hereinafter referred to as "Chenwei Ecological Park"), reached an enforcement settlement in April 2024 regarding a legal dispute with Rugao City Lvsifang Landscape Greening Engineering Co., Ltd. (see company announcement No. 2024-09). Due to some outstanding payment amounts not being paid on schedule, Chenwei Ecological Park has been listed as a dishonest person subject to enforcement by the People's Court of Zhaoyang District, Zhaotong City.
Jiangsu Sihuan Bioengineering Co., Ltd's (SZSE:000518) 19% Gain Last Week Benefited Both Individual Investors Who Own 55% as Well as Insiders
Sihuan Biology: Report for the third quarter of 2024
Risks Still Elevated At These Prices As Jiangsu Sihuan Bioengineering Co., Ltd (SZSE:000518) Shares Dive 27%
